IRWD
Ironwood Pharmaceuticals Inc
3.90$
+3.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 100.0% | 634.1% | 338.9% | 287.0% | 224.5% | 185.2% | 0.6% | 31.5% | 33.5% | 0.0% | 0.7% | 6.5% | 9.4% | 31.6% | 0.8% | 17.0% | 0.3% | 1.4% | 2.1% | 0.6% | |
| – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 99.4% | 68.5% | 66.5% | 100.0% | 99.3% | 93.5% | 90.6% | 68.4% | 99.2% | 83.0% | 99.7% | 98.6% | 97.9% | 100.0% | |
| 1,131.9% | 547.1% | 269.2% | 235.1% | 176.6% | 130.7% | 75.5% | 447.4% | 133.3% | 72.7% | 50.9% | 49.7% | 48.0% | 28.5% | 22.6% | 17.0% | 10.8% | 26.2% | 31.7% | 32.1% | |
| – | – | – | 66.4% | 61.9% | 69.7% | 61.6% | 538.6% | 154.8% | 83.7% | 63.3% | 78.2% | 69.6% | 40.3% | 35.9% | 26.9% | 28.3% | 33.4% | 41.1% | 27.8% | |
| 1,320.9% | 650.6% | 351.7% | 301.6% | 238.6% | 200.4% | 147.8% | 1,169.9% | 288.1% | 156.5% | 114.5% | 129.9% | 120.0% | 40.4% | 62.5% | 26.8% | 38.7% | 312.2% | 71.4% | 59.9% | |
| -1,261.0% | -550.6% | -251.7% | -201.6% | -138.6% | -100.4% | -48.4% | -1,101.4% | -221.6% | -68.3% | -18.9% | -25.9% | -68.9% | 28.0% | 36.7% | 56.1% | 61.0% | -213.5% | 26.5% | 40.1% | |
| 6.9% | 2.5% | 1.5% | 1.3% | 0.4% | 0.1% | 0.0% | 91.8% | 27.7% | 20.8% | 14.3% | 12.2% | 10.9% | 8.5% | 7.6% | 7.5% | 1.9% | 4.9% | 9.4% | 11.1% | |
| -1,187.2% | -508.0% | -247.7% | -203.9% | -135.3% | -98.4% | -48.3% | -1,192.3% | -248.1% | -95.4% | -29.8% | -39.2% | -81.5% | 13.8% | 27.9% | 48.5% | 61.5% | -214.1% | 18.6% | 23.6% | |
| – | -1.4% | -3.7% | -0.8% | -6.7% | 0.0% | -7.5% | -51.3% | 11.2% | 12.7% | 13.9% | 11.5% | -1.7% | 17.3% | 0.7% | -79.2% | 18.8% | 18.9% | 18.3% | 15.5% | |
| -1,184.1% | -504.1% | -242.5% | -197.2% | -120.8% | -98.5% | -48.3% | -1,192.3% | -248.1% | -95.4% | -29.8% | -39.2% | -81.5% | 5.0% | 27.3% | 127.7% | 42.6% | -226.4% | 0.3% | 8.1% | |
| -1,140.2% | -489.0% | -233.4% | -186.4% | -120.8% | -83.2% | -40.9% | -1,050.1% | -205.5% | -66.8% | -11.4% | -11.1% | -41.7% | 30.0% | 36.4% | 56.5% | 63.7% | 44.6% | 27.8% | 35.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.